How Long Does Stem Cell Therapy Last? The 6-to-18 Month Response Window

Stem cell therapy produces a clinical response window of 6 to 18 months for most appropriately selected patients. Duration varies based on condition type, severity, the pace of the underlying degenerative process, and patient-specific biological factors.

FDA Disclaimer: DayZero™ stem cell therapies have not been FDA-approved and are not intended to diagnose, treat, cure, or prevent any disease. All protocols supervised by [MD_PLACEHOLDER] MD under Florida SB 1768.

Why the Response Window Spans 6 to 18 Months

The 6 to 18 month range reflects two clinical realities.

The lower bound (6 months) applies to patients with rapidly progressive underlying conditions (severe OA with ongoing mechanical loading, uncontrolled metabolic disease) where the biological repair signals from MSCs are being outpaced by the ongoing degenerative process.

The upper bound (18+ months) applies to patients with stable conditions at an earlier stage of degeneration, where the biological repair environment established by stem cell therapy persists without being overwhelmed by continued tissue damage.

In conditions with a resolved or controllable root cause, some patients maintain improvements well beyond 18 months.

Factors That Affect Duration

Condition severity at the time of treatment. Mild-to-moderate conditions treated earlier in their progression tend to produce more durable responses than advanced conditions where significant tissue loss has already occurred.

Underlying disease control. Diabetic neuropathy patients who achieve better blood sugar control after treatment maintain improvements longer. OA patients who reduce joint loading through weight management maintain improvements longer. The biological repair process competes with the continuing degenerative process; controlling the degenerative driver extends the response.

Patient biology and health. Overall health, inflammatory burden, hormonal status, and nutritional adequacy all affect how well the body sustains the repair environment established by stem cell therapy.

When Re-Treatment Is Considered

Re-treatment with DayZero™ stem cells is considered at 6 to 12 months for patients who showed strong initial response and are experiencing gradual return of symptoms. A second treatment at this interval can extend the response and produce an additional improvement cycle.

Re-treatment is not a mandatory feature of the protocol at Rebuild Regen Medical Clinic at 3320 N Federal Hwy #101, Lighthouse Point, FL. The decision is clinical, based on the patient's symptom trajectory and the underlying condition's natural history.

When Stem Cell Therapy Is Not Sufficient Long-Term

Progressive conditions where the underlying driver is not being controlled, end-stage degeneration without viable repair substrate, and conditions requiring structural surgical intervention will not maintain stem cell therapy responses regardless of re-treatment frequency.

Contact Rebuild Regen at (954) 953-4208 for a consultation on your specific condition and expected response duration.